The story of the blue pill offers a complicated case study for analysts eyeing pharma. While initial sales were astounding, recent patent expiration and the arrival of cheaper versions have severely impacted https://harleycqls532400.blogunteer.com/39750785/the-blue-pill-and-the-pharmaceutical-industry-a-risky-stake